Table 1.
Patients’ characteristics by the presence of fractures.
| Parameter | Group I (Without Fractures) n = 67 |
Group II (With Fractures) n = 71 |
p-Value |
|---|---|---|---|
| Age, years (X ± DS) | 78.2 ± 2.5 | 78.9 ± 2.3 | 0.08 |
| Male gender, n (%) | 29 (43%) | 26 (37%) | 0.47 |
| Body mass index, kg/m2 | 28.39 ± 5.14 | 29.51 ± 6.19 | 0.25 |
| Obesity, n (%) | 26 (39%) | 17 (24%) | 0.05 |
| Smoker, n (%) | 36 (54%) | 37 (52%) | 0.81 |
| Comorbidities, number (X ± SD) | 1.47 ± 0.63 | 3.73 ± 1.44 | <0.0001 |
| Number steps/day, (X ± SD) | 2424.67 ± 1653.91 | 2933.75 ± 1610.24 | 0.06 |
| Multisite pain, n (%) | 34 (51%) | 28 (39%) | 0.15 |
| Total bone mineral density (g/cm2) | 2.36 ± 0.72 | 2.27 ± 0.64 | 0.26 |
| Risk of fall, (X ± SD) | 11.31 ± 3.12 | 15.63 ± 2.99 | <0.0001 |
| Number of fractures, (X ± SD) | 0 | 1.15 ± 0.33 | - |
| Sleep disturbances, n (%) | |||
| Type 1 | 18 (27%) | 8 (11%) | 0.01 |
| Type 2 | 20 (30%) | 10 (14%) | 0.02 |
| Type 3 | 14 (21%) | 26 (37%) | 0.03 |
| Type 4 | 15 (22%) | 27 (38%) | 0.04 |
| Medication for sleep disturbances | |||
| Zopiclone | 29 (43%) | 41 (75%) | <0.001 |
Chi-square tests were used to compare categorical data and Student’s t-tests to compare continuous data. Abbreviations: X, arithmetic mean; SD, standard deviation; n, number.